FMTX
Forma Therapeutics Holdings Inc
Price:  
20.01 
USD
Volume:  
739,166.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FMTX WACC - Weighted Average Cost of Capital

The WACC of Forma Therapeutics Holdings Inc (FMTX) is 9.4%.

The Cost of Equity of Forma Therapeutics Holdings Inc (FMTX) is 14.75%.
The Cost of Debt of Forma Therapeutics Holdings Inc (FMTX) is 5.00%.

Range Selected
Cost of equity 12.10% - 17.40% 14.75%
Tax rate 9.90% - 24.70% 17.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.3% - 10.6% 9.4%
WACC

FMTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.79 2.24
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.10% 17.40%
Tax rate 9.90% 24.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 8.3% 10.6%
Selected WACC 9.4%